IGF1 and type 2 diabetes mellitus: In type 2 DM (T2DM), elevated insulin levels result in increased bioavailability of insulin‐like growth factor‐1 (IGF‐1) by reducing hepatic production of IGF‐binding proteins (IGFBPs) and PC cells highly express receptors of high‐affinity insulin and IGF‐1.26, 27